Elanco Animal Health (NYSE: ELAN) reported Q1 EPS of $0.36, $0.01 better than the analyst estimate of $0.35. Revenue for the quarter came in at $1.23 billion versus the consensus estimate of $1.22 billion.

GUIDANCE:

Elanco Animal Health sees Q2 2022 EPS of $0.22-$0.28, versus the consensus of $0.34. Elanco Animal Health sees Q2 2022 revenue of $1.16-1.2 billion, versus the consensus of $1.27 billion.

For earnings history and earnings-related data on Elanco Animal Health (ELAN) click here.